Esperion Therapeutics
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Esperion Therapeutics
Esperion Therapeutics, Inc. 是一家製藥公司，開發和銷售用於治療低密度脂蛋白膽固醇升高患者的藥物。其主要候選產品是 NEXLETOL（bempedoic acid）和 NEXLIZET（bempedoic acid 和 ezetimibe）片劑，用於治療動脈粥樣硬化性心血管疾病或雜合子家族性高膽固醇血症患者。公司與Daiichi Sankyo Europe GmbH 有許可和合作協議；和 Serometrix 獲得其口服小分子 PCSK9 抑製劑項目的許可。 Esperion Therapeutics, Inc.成立於2008年，總部位於密歇根州安娜堡。
如何購買 Esperion Therapeutics (ESPR)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 ESPR
透過 RockFlow App 或網頁端搜尋 ESPR，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.